Jenn Segar

[Martín Angel @Martin_AngelMD]

Avelumab Manteinance is the new standar of care in Bladder Cancer. #blcsm #OncoAlert #ASCO20 #UroOncoIAF

[Fabio Schutz @FabioSchutz78]

Another presentation about the accuracy of PSMA PET for staging of localized prostate cancer. Sensitivity 40% / specificity 95%. PSMA PET should become SOC for high risk localized prostate cancer, and could significantly shift staging and change management. #ASCO20

[NEJM @NEJM]

Approximately 15 to 20% of gastric adenocarcinomas express HER2. In an RT, the antibody-drug conjugate led to higher response and longer overall survival than physician’s choice of therapy among patients with relapsed disease. #ASCO20

[GTG @GrupoGTG]

Sobrero et al, final results of IDEA adjuvant collaboration:

OS, DFS and toxicity results continue to support the use of 3m adjuvant CAPOX for the vast majority of stage III colon cancer pts.

#ASCO20

[Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ @APassaroMD]

💥 #ASCO20 #LCSM ADAURA
Clear improvement of DFS in favour OSI but many open questions are emerged.
DFS was highly significant, of course potentially practice changing but...
Would you feel safe to use Osi in adjuvant thinking about your patients/OS?

[Fabio Schutz @FabioSchutz78]

Updated results of Ph2 KeyNote-146 w/ Pembro-Lenvatinib in mRCC patients 2L/3L. Prior regimens: anti-PD1/L1 (100%), Anti-PD1/L1+anti-VEGFR (65%) and Ipi-Nivo (37%). Very high ORR 55%, including all cohorts #ASCO20. Should this combo be tested in 2L/3L in Ph3 trials?

[Mark Lewis, MD, FASCO @marklewismd]

So I might need #asco20 to bail me out

My wife just walked in to finding me staring at my phone and whistling “man, just look at those curves!!!”

[Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ @APassaroMD]

🔥🔥 Kaboooom!
#ASCO20 #LCSM
Finally a target agent for HER2-mutated NSCLC: Interim results of DESTINY-Lung01 (42 pts)
mDOR: 7.75 mo
ORR: 61.9%
DCR: 90.5%
Estimated mPFS = 14.0 mo
👉All pts (42/42) had TEAEs; 64.3% were grade ≥ 3 (52.4% drug-related)

[Duilio Rocha @duiliorocha_onc]

#1 GI cancer practice-changing data in #ASCO20: total neoadjuvant therapy in rectal cancer.

RAPIDO, PRODIGE, OPRA: TNT ⬆️pCR, ⬆️DFS, 3-y organ preservation in up to 59% pts.

Questions:
- Is triplet necessary?
- Is short course RT reasonable as organ preservation strategy?

[Stash @Stash]

Garbage day! Ha ha ha ha...
$WM #StashStockParty

May Fest. Day 3 🗑➡️https://t.co/96ocgRtnHN

[Stash @Stash]

Thank you Stashers for uniting for an epic run. You all claimed over 55,000 fractional shares of stock today!

See you at tomorrow’s #StashStockParty...and #MayThe4thBeWithYou... ⭐️⚔️

https://t.co/96ocgRtnHN

[Stash @Stash]

#StashStockParty presents The Cantina After-Party
☠️⭐️🚀💥⚔️🧙‍♂️🎲🌑🍹🎺🎶🌌
---------------------------------------
• 4 parties tomorrow, every 30 min
• Bring allies to boost the $$$
• Follow @Stash to stay briefed
---------------------------------------
⬇️⬇️⬇️#Maythe4th⬇️⬇️⬇️

[Stash @Stash]

Better parties. Better people. $PZZA #StashStockParty.

4/20 Fest. Day 20 🍕➡️ https://t.co/96ocgRtnHN

[Paigambar Raj @PgambarRaj]

Best part of #SABCS19 is reconnecting with my Vail PDG colleagues and friends! #vailworkshop19 #SABCS19 @SABCSSanAntonio @DrDawnHershman @oreganruth @TariKingMD @AACR @KhanSabrinaMD

[Jenn Segar @JennSegar]

@AmericanAir Romantic trip to Maui starts with us being separated in middle seats despite us book our seats before through @CostcoTravel